Biochemistry Of Bone Metabolism Flashcards Preview

Endocrine > Biochemistry Of Bone Metabolism > Flashcards

Flashcards in Biochemistry Of Bone Metabolism Deck (23)
Loading flashcards...
1
Q

Bone homeostasis biochemistry brief overview

A

Bone matrix = collagen and hydroxyapatite

Osteoblasts = grow and lay bone

Osteoclasts = destroy bone via RANKL signaling and kinase cascades

Bone grows from hydroxyapatite crystals

4 phases

1) osteoclast resorption
2) osteoblast activation and matrix formation
3) mineralization
4) resting phase
* *all 4 phases in one movement takes 160-200 days**

2
Q

How is calcium and phosphate moved in and about of bone by osteoclasts?

A

Requires facilitated transport channels since osteoblasts have strong tight junctions

Phosphate is also actively produced by secretion of phosphate contains compounds (including ATP)

3
Q

How does hydroxyapatite form?

A

From the combination of phosphate, calcium and water at a slightly alkaline pH
- however as hydroxyapatite crystals precipitate, there is release of H+ ions forming acid which rapidly lowers the pH and prevents excess hydroxyapatite crystal formation

the acid is removed in unknown mechanism, however to remove hydroxyapatite, osteoclasts pump H+ ions into the bone area

4
Q

Parathyroid hormone and bone regulation

A

PTH is produced by chief cells in the parathyroid glands

Actions

  • increase cAMP in DCTs of renal cells to promote reabsorption of calcium
  • activates PCT cells to increase activation of Vitamin D activity (1,25)
  • decrease phosphate reabsorption
  • increase osteoclast and osteoblast activity
  • increases serum calcium and decreases serum phosphate
5
Q

What is the pathway of vitamin D activation

A

1) 7-dehydrocholesterol -> cholecalciferol from UV light
2) cholecalciferol -> vitamin D3 (25-OH-D3) in the liver from 25-hydroxylase enzymes

3) 25-OH-D3 -> 1,25 -diOH in the kidney via the enzyme 1-hydroxylase
- 1,25-diOH has a negative feedback on 1-hydroxaylase

4) 1,25-diOH -> intestines to bind to calbindin proteins or just floats around in the blood

6
Q

How does PTH affect osteoclasts and osteoblasts

A

PTH binds to PTH1R and PTH2R

PTH1R = on both clasts and blasts

PTH2R = found not on osteoclasts on blasts

PTH/PTH1R signaling:

  • decreases osteoclast V-ATPasae activity (slows down H+ ion secretion and bone breakdown)
  • at the same time, it also increases RANKL secretion from osteoblasts which promotes osteoclast gene expression and upregulates # of osteoclasts
7
Q

How does magnesium levels inhibit PTH?

A

Severely chronic magnesium Deficency can inhibit PTH release from secretory vesicles

8
Q

What three forms of calcium are present at all times in the body

A

1) ionized calcium (50%)
- this is the physically active form

2) protein bound to albumin and calmodulin (40%)
- this is inactive

3) complexed to compounds to citrate/phosphate ions

9
Q

What are the effects of calcium entering cytoplasm?

A

Calcium moving to cytoplasm (low concentration) from organelles and ECF (high concentration) activates gPCR signaling, PIP hydrolysis, PKC activation and cellular effects

all lead to calcium replenishment to organelles and ECF

10
Q

Calcitonin effects

A

Reduces blood calcium levels and is secreted in response to hypercalcemia

Has two effects:

  • suppresses renal tubular reabsorption of calcium
  • inhibits bone resorption by minimizing flux of calcium from bone -> blood

overall has minimal influence on plasma calcium levels at any time

11
Q

What are other hormones that regulate bone calcium

A

Thyroid hormone
- stimulates bone resorption

Adrenal and gonadal steroids (especially estrogens and testosterone)

  • stimulates osteoblasts and inhibit osteoclast (bone growth)
  • also increases intestinal calcium absorption and decrease renal calcium and phosphate excretion

Leptin
- inhibits bone formation in unknown ways

12
Q

Estrogen effects on bone

A

Binds to ERa receptors on multiple aspects of bones

1) chondrocytes
- turns on nuclear-initiated signaling to initiate epiphyseal closure

2) periosteal cells
- unknown mechanism but attenuates apposition
- stimulation of periosteal apposition in (males only)

3) osteoprogenitors
- turns on non-nuclear-initiated signaling which attenuates endocortical bone reabsorption

4) osteoclasts
- initiates nuclear-initiated signaling which attenuates trabecular bone resorption

also with mechanical strain induces to unliganded ERa receptors on osteoprogenitors to stimulate periosteal apposition

13
Q

Androgens affects on bone

A

Binds to AR receptors on osteoblasts and osteocytes to stimulate trabecular bone formation

14
Q

Glucocorticoids (cortisol/aldosterone) affect on bones

A

Osteoblast effects

  • decreases proliferation/differentiation
  • increases apoptosis of osteoblasts
  • decreases matrix formation up up regulating collagenase 3 enzymes and dose regulate ting collagen 1
  • decreases osteocalcin

Osteoclasts effects

  • increases cell recruitment
  • increases differentiation to osteoclasts
  • increases osteoclasts -> bone surface

Also indirectly enhances PTH responsiveness, without elevating levels of PTH

15
Q

Growth hormone effects on bone

A

GH effects on bone
1) binds via IGF-1 on chondrocytes which promotes endochondrial ossification (linear growth)

2) binds via IGF-1 on osteoclasts to promote bone resorption
3) binds GH directly on osteoblasts to stimulate more IGF-1 release which works osteoclasts

overall increases urinary excretion of calcium, decreases a urinalysis excretion of phosphate, increases linear growth and bone turnover

16
Q

Vitamin K functions on bone

A

Improves osteoblast functions and stimulates bone formation via increasing genesis of osteoblasts and increasing RANK and alkaline phosphatase activity

Inhibits bone resorption via inducing osteoclast apoptosis and decreasing RANKL and increasing OPG

also increases gamma-carboxylation which regulates bone mineralization

warfarin blocks vitamin K action which decreases all of these actions

17
Q

Osteoporosis and osteopenia information

A

A reduction of bone mineral density with an increased susceptibility to fractures

Rates of bone loss accelerate in women after loss of estrogen production (menopause)

Use DEXA scans to determine severity of bone density reduced

18
Q

Hyperparathyroidism clinical symptoms

A

Most patients either present asymptomatic or kidney stones

Other symptoms

  • lethargy
  • drowsiness
  • inability to concentrate
  • depression
  • confusion
  • proximal muscle weakness, hypotonia, decreased reflexes
  • polyuria, polydipsia, dehydration
  • nausea, vomiting, anorexia
  • increased risk of peptic ulcers
  • increased risk of pancreatitis
  • broad T-waves in ECG
  • corneal calcifications
  • bone pain and fractures
19
Q

What is the most common cause of hypoparathyroidism?

A

Neck surgery

20
Q

Pseudohypoparathyrodism

A

Shows hypocalcemia, hyperphosphatemia with an INCREASED concentration of PTH

Confirmation of the diagnosis is made by demonstrating a lack of increase in plasma or urinary cAMP in response to PTH infusion

**classic form is due to end-organ resistance to PTH caused by a genetic defect resulting in an abnormal regulatory G protein subunit

21
Q

Renal osteodystrophy

A

CKD causes decreased ability to form active vitamin D as well as increased retention of PO43-
- this results in hyperphosphatemia and hypocalcemia

Will also cause a rise in PTH in blood, however the kidney cant respond well

Treatment = vitamin D w/ PO43- reduction therapy to prevent further bone loss and excessive hydroxyapatite crystal formation

22
Q

Paget disease of bone

A

Ares of accelerated bone turnover due to increased focal osteoclast activity which leaves with “punched-out” lesions on bones that are disorganized

is caused by increased sensitivity of osteoclasts to calcitriol and RANKL and increased plasma alkaline phosphatase

Shows elevated collagen and hydroxyproline in the urine and plasma

Treatment = bisphosphonates (present with anti-osteoclast activity)

23
Q

How do PTH and active vitamin D differ in effects on serum blood concentration?

A

PTH = increases calcium and decreases phosphate

1,25OH = increases both calcium and phosphate

Decks in Endocrine Class (46):